SEC Form 5 · accession 0001213900-15-001193
OxySure Therapeutics, Inc. · OXYS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julian T Ross
Officer — CEO · Director · 10% Owner
Period of report
Dec 31, 2014
Accepted (ET)
Feb 17, 2015 · 7:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001413797
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Feb 16, 2015 | G | 15,000 | $0.00 | D | 14,025,761 | I | Held by JTR Investments, Limited |
| Common stockF2,F3 | Dec 31, 2014 | L | 3,950 | $0.849 | A | 383,824 | D | |
| Common stockF4,F5 | Feb 6, 2015 | L | 9,400 | $0.693 | A | 393,224 | D | |
| Common stockF6 | Feb 10, 2015 | J | 190,000 | $0.526 | D | 203,224 | D | |
| Common stockF7 | Feb 14, 2015 | J | 60,000 | $0.10 | D | 143,224 | D | |
| Common stock | holding | — | — | — | 14,040,761 | I | Held by JTR Investments, Limited | |
| Common stock | holding | — | — | — | 400,000 | I | Held by The Ross Family Trust | |
| Common stock | holding | — | — | — | 379,874 | D | ||
| Common stock | holding | — | — | — | 116,182 | I | Held by spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options (right to buy)F8,F9,F11 | $0.25 | Jun 5, 2013 | A | 120,000 | A | Apr 5, 2014 | Dec 5, 2019 | Common stock | 120,000 | 1,417,488 | D |
| Options (right to buy)F8,F9,F12 | $0.72 | Jul 2, 2014 | A | 150,000 | A | Jul 2, 2015 | Jul 2, 2022 | Common stock | 150,000 | 150,000 | I |
| Options (right to buy)F10,F8,F9 | $0.25 | holding | — | — | — | Jul 5, 2013 | Feb 5, 2024 | Common stock | 1,297,488 | 1,297,488 | D |
Explanation of responses
- F1Bona fide gift to Ed Huntsberry, a consultant of the Company.
- F10Comprises vested options issued pursuant to various employment agreements and related amendments under the Company's 2004 Stock Option Plan.
- F11Comprises vested options as at February 17, 2015; 30,000 options are issued pursuant to that certain employment agreement renewal dated June 5, 2013 and 90,000 options are issued pursuant to that certain employment agreement renewal dated June 5, 2014, under the Company's 2004 Stock Option Plan.
- F12Comprises options issued under the Company's 2004 Stock Option Plan. Options vest as to 50,000 shares on 7/2/2015; 50,000 shares on 7/2/2016; and 50,000 shares on 7/2/2017.
- F2Small acquisitions (open market purchases) under Rule 16a-6 during the period December 3, 2014 through December 31, 2014.
- F3Per share acquisition prices ranging from $.7499 to $.94, with an aggregate per share price for all the transactions of $.849.
- F4Small acquisitions (open market purchases) under Rule 16a-6 during the period January 8, 2015 through February 6, 2015.
- F5Per share acquisition prices ranging from $.645 to $.75, with an aggregate per share price for all the transactions of $.693.
- F6Transferred to Tim Hutton, the spouse of Vicki Jones, a Director of the Company as part of a settlement agreement.
- F7Transferred to Phong Le, a shareholder of the Company as part of an agreement.
- F8Represents the earliest date(s) that any options became exercisable.
- F9Represents the latest date(s) that any vested options expire.